BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/27/2018 8:56:32 AM | Browse: 1309 | Download: 2518
 |
Received |
|
2018-10-02 09:00 |
 |
Peer-Review Started |
|
2018-10-02 12:59 |
 |
First Decision by Editorial Office Director |
|
2018-11-01 03:15 |
 |
Return for Revision |
|
2018-11-01 09:16 |
 |
Revised |
|
2018-11-07 03:16 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2018-11-16 07:32 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2018-11-16 18:43 |
 |
Articles in Press |
|
2018-11-16 18:43 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2018-12-26 02:54 |
 |
Publish the Manuscript Online |
|
2018-12-27 08:56 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Winn Aung, Atsushi B Tsuji, Aya Sugyo, Hiroki Takashima, Masahiro Yasunaga, Yasuhiro Matsumura and Tatsuya Higashi |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Supported by (partially) a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, to Aung W |
17K10460 |
|
| Corresponding Author |
Winn Aung, MBBS, PhD, Senior Researcher, Department of Molecular Imaging and Theranostics, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan. winn.aung@qst.go.jp |
| Key Words |
Pancreatic cancer; Anti-tissue factor antibody; Indocyanine green; Photoimmunotherapy; Near-infrared |
| Core Tip |
We examined whether anti-tissue factor (TF) antibody 1849-indocyanine green (ICG) conjugate (1849-ICG) induced the photoimmunotherapeutic effect in a pancreatic cancer xenograft. There was no report about employing 1849-ICG conjugate which selectively binds the target antigen TF for near-infrared photoimmunotherapy (NIR-PIT) of tumor, though some studies have suggested the usefulness of anti-TF 1849 in cancer imaging and therapy. Our study proposes for the first time that 1849-ICG conjugate is a desirable candidate for new treatment modality NIR-PIT of pancreatic cancer after evaluating its cytotoxic and antitumor effects via in vitro and in vivo studies in mouse model of pancreatic cancer. |
| Publish Date |
2018-12-27 08:56 |
| Citation |
Aung W, Tsuji AB, Sugyo A, Takashima H, Yasunaga M, Matsumura Y, Higashi T. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody. World J Gastroenterol 2018; 24(48): 5491-5504 |
| URL |
https://www.wjgnet.com/1007-9327/full/v24/i48/5491.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v24.i48.5491 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.